These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34950454)

  • 81. Collagenase clostridium histolyticum for the treatment of Dupuytren's contracture: systematic review and economic evaluation.
    Brazzelli M; Cruickshank M; Tassie E; McNamee P; Robertson C; Elders A; Fraser C; Hernandez R; Lawrie D; Ramsay C
    Health Technol Assess; 2015 Oct; 19(90):1-202. PubMed ID: 26524616
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT.
    Wu O; McCartney E; Heggie R; Germeni E; Paul J; Soulis E; Dillon S; Ryan C; Sim M; Dixon-Hughes J; Agarwal R; Bodenham A; Menne T; Jones B; Moss J
    Health Technol Assess; 2021 Jul; 25(47):1-126. PubMed ID: 34318743
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
    Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
    Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
    [TBL] [Abstract][Full Text] [Related]  

  • 84. 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
    Iveson T; Boyd KA; Kerr RS; Robles-Zurita J; Saunders MP; Briggs AH; Cassidy J; Hollander NH; Tabernero J; Haydon A; Glimelius B; Harkin A; Allan K; McQueen J; Pearson S; Waterston A; Medley L; Wilson C; Ellis R; Essapen S; Dhadda AS; Harrison M; Falk S; Raouf S; Rees C; Olesen RK; Propper D; Bridgewater J; Azzabi A; Farrugia D; Webb A; Cunningham D; Hickish T; Weaver A; Gollins S; Wasan H; Paul J
    Health Technol Assess; 2019 Dec; 23(64):1-88. PubMed ID: 31852579
    [TBL] [Abstract][Full Text] [Related]  

  • 85. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.
    Wang D; Connock M; Barton P; Fry-Smith A; Aveyard P; Moore D
    Health Technol Assess; 2008 Feb; 12(2):iii-iv, ix-xi, 1-135. PubMed ID: 18093448
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Falls and health status in elderly women following first eye cataract surgery: an economic evaluation conducted alongside a randomised controlled trial.
    Sach TH; Foss AJ; Gregson RM; Zaman A; Osborn F; Masud T; Harwood RH
    Br J Ophthalmol; 2007 Dec; 91(12):1675-9. PubMed ID: 17585002
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cost-effectiveness of a model consultation to support self-management in patients with osteoarthritis.
    Oppong R; Jowett S; Lewis M; Clarkson K; Paskins Z; Croft P; Edwards JJ; Healey E; Jordan KP; Morden A; Ong BN; Porcheret M; Finney A; Hay E; Dziedzic K
    Rheumatology (Oxford); 2018 Jun; 57(6):1056-1063. PubMed ID: 29554338
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: an economic evaluation alongside a randomised controlled trial.
    Wilson EC; Shulgina L; Cahn AP; Chilvers ER; Parfrey H; Clark AB; Twentyman OP; Wilson AM
    Pharmacoeconomics; 2014 Jan; 32(1):87-99. PubMed ID: 24307539
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cost-effectiveness of an educational intervention to reduce potentially inappropriate medication.
    Rantsi M; Pitkälä KH; Kautiainen H; Hyttinen V; Kankaanpää E
    Age Ageing; 2022 May; 51(5):. PubMed ID: 35604803
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cost-utility analysis of standard dressing compared with incisional negative-pressure wound therapy among patients with closed surgical wounds following major trauma to the lower limb.
    Png ME; Madan JJ; Dritsaki M; Achten J; Parsons N; Fernandez M; Grant R; Nanchahal J; Costa ML;
    Bone Joint J; 2020 Aug; 102-B(8):1072-1081. PubMed ID: 32731829
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Exposure-based treatments for childhood abuse-related post-traumatic stress disorder in adults: a health-economic evaluation.
    Kullberg MJ; Schoorl M; Oprel DAC; Hoeboer CM; Smit F; van der Does W; de Kleine RA; van Minnen A; van den Hout W
    Eur J Psychotraumatol; 2023; 14(1):2171752. PubMed ID: 37052103
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cost-utility analysis of cast compared to removable brace in the management of adult patients with ankle fractures.
    Nwankwo H; Mason J; Costa ML; Parsons N; Redmond A; Parsons H; Haque A; Kearney RS
    Bone Jt Open; 2022 Jun; 3(6):455-462. PubMed ID: 35658671
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cost-utility and cost-effectiveness analysis of a clinical medication review focused on personal goals in older persons with polypharmacy compared to usual care: Economic evaluation of the DREAMeR study.
    Verdoorn S; van de Pol J; Hövels AM; Kwint HF; Blom JW; Gussekloo J; Bouvy ML
    Br J Clin Pharmacol; 2021 Feb; 87(2):588-597. PubMed ID: 32520439
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial.
    Mason JM; Chalmers JR; Godec T; Nunn AJ; Kirtschig G; Wojnarowska F; Childs M; Whitham D; Schmidt E; Harman K; Walton S; Chapman A; Williams HC;
    Br J Dermatol; 2018 Feb; 178(2):415-423. PubMed ID: 28940316
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cost-effectiveness of transdiagnostic group cognitive behavioural therapy for anxiety disorders
    Chapdelaine A; Vasiliadis HM; Provencher MD; Norton PJ; Roberge P
    Psychol Med; 2023 Jan; ():1-13. PubMed ID: 36695038
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cost-effectiveness of implementing a digital psychosocial intervention for patients with psychotic spectrum disorders in low- and middle-income countries in Southeast Europe: Economic evaluation alongside a cluster randomised trial.
    Feng Y; Roukas C; Russo M; Repišti S; Džubur Kulenović A; Injac Stevović L; Konjufca J; Markovska-Simoska S; Novotni L; Ristić I; Smajić-Mešević E; Uka F; Zebić M; Vončina L; Bobinac A; Jovanović N
    Eur Psychiatry; 2022 Aug; 65(1):e56. PubMed ID: 36017673
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cost-Utility Analysis of a Medication Adherence Management Service Alongside a Cluster Randomized Control Trial in Community Pharmacy.
    Valverde-Merino MI; Martinez-Martinez F; Garcia-Mochon L; Benrimoj SI; Malet-Larrea A; Perez-Escamilla B; Zarzuelo MJ; Torres-Robles A; Gastelurrutia MA; Varas-Doval R; Peiro Zorrilla T; Garcia-Cardenas V
    Patient Prefer Adherence; 2021; 15():2363-2376. PubMed ID: 34729007
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Ciclosporin compared with prednisolone therapy for patients with pyoderma gangrenosum: cost-effectiveness analysis of the STOP GAP trial.
    Mason JM; Thomas KS; Ormerod AD; Craig FE; Mitchell E; Norrie J; Williams HC;
    Br J Dermatol; 2017 Dec; 177(6):1527-1536. PubMed ID: 28391619
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cost-utility analysis of interventions to improve effectiveness of exercise therapy for adults with knee osteoarthritis: the BEEP trial.
    Kigozi J; Jowett S; Nicholls E; Tooth S; Hay EM; Foster NE;
    Rheumatol Adv Pract; 2018; 2(2):rky018. PubMed ID: 30506022
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial.
    Hartman L; El Alili M; Cutolo M; Opris D; Da Silva J; Szekanecz Z; Buttgereit F; Masaryk P; Bos R; Kok MR; Paolino S; Coupé V; Lems WF; Boers M;
    Semin Arthritis Rheum; 2022 Dec; 57():152109. PubMed ID: 36335684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.